title: Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat.
abstract: We investigated the role of the polyol pathway in the pathogenesis of glomerular basement membrane thickening in galactosaemic rats, an animal model that develops basement membrane lesions comparable to those of human diabetic subjects. Normotensive Wistar-Kyoto rats fed a 30% galactose diet for nine months developed significant glomerular basement membrane thickening by comparison with rats on a control test diet (p = 0.008). However, addition of an aldose reductase inhibitor, sorbinil (250 mg/kg diet), to the galactose diet did not prevent the increase in glomerular basement membrane thickness. Furthermore, by using a quantitative electron microscopic immunogold technique, we examined biochemical alterations in the composition of glomerular basement membranes in this animal model. The labelling density (comparable to relative concentration) of collagen type IV in thickened glomerular basement membranes of galactosaemic animals was significantly increased by comparison to those of control rats (p = 0.015). However, there was no significant difference in labelling densities of laminin and heparan sulfate proteoglycan core protein of these animals. Thus, our results indicate that an increase in glomerular basement membrane thickness accompanied by an increase in the labelling density of collagen type IV occurs in the galactosaemic rats, but this thickening is not prevented by sorbinil at the dose used in this experiment. Our study raises the strong possibility that glomerular basement membrane thickening in galactosaemic rats may not be due to excessive polyol pathway activity.
authors.affiliation: Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan.
authors.forename: A
authors.initials: A
authors.lastname: Das
authors.forename: R N
authors.initials: RN
authors.lastname: Frank
authors.forename: N L
authors.initials: NL
authors.lastname: Zhang
mesh_terms: D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D001485:Basement Membrane / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D002196:Capillaries / Q000187:drug effects / Q000473:pathology* / Q000648:ultrastructure; D003094:Collagen / Q000032:analysis; D005260:Female; D005690:Galactose / Q000633:toxicity*; D007093:Imidazoles / Q000494:pharmacology*; D048289:Imidazolidines; D007678:Kidney Glomerulus / Q000098:blood supply* / Q000473:pathology / Q000648:ultrastructure; D016253:Microscopy, Immunoelectron; D051381:Rats; D011921:Rats, Inbred WKY
chemical_list: D007093:Imidazoles; D048289:Imidazolidines; D003094:Collagen; D000449:Aldehyde Reductase; C026411:sorbinil; D005690:Galactose